EGRP News Flash - March 9, 2012

Funding Opportunities for Department of Defense Breast Cancer Research Program

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $120 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research. The BCRP is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The following funding mechanisms are available for FY12:

  1. Clinical Translational Research Award - Investigators at or above the level of Assistant Professor (or equivalent) are eligible. This award supports the acceleration of research with a high potential for direct clinical translation that will result in significant improvements over current approaches to breast cancer prevention and/or therapy. Applications will be supported in two stages. Stage I will enable completion of preclinical translational studies and Food and Drug Administration approvals (if needed). Stage II will initiate and execute the prospective clinical trial. Maximum funding is for $12 million in direct costs (plus indirect costs). The period of performance is not to exceed 5 years.

    A pre-application is required and is due May 3, 2012. Application submission is by invitation only.

  2. Era of Hope Scholar Award - Independent, non-mentored investigators within 6 years of their last mentored position are eligible as of the application submission deadline. This award supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields. Individuals should exhibit strong potential for leadership in the breast cancer community. Maximum funding is for $2.5 million in direct costs (plus indirect costs). The period of performance is not to exceed 5 years.

    Letters of intent are due April 5, 2012. Applications are due April 19, 2012.

  3. Idea Award - Investigators at all academic levels (or equivalent) are eligible. This award supports innovative, high-risk/high-reward research ideas that have extraordinary potential to yield highly impactful data. Innovation and impact are the most important review criteria. Preliminary data are allowed, but not required. The Partnering Principal Investigator (PI) Option supports combining expertise of two PIs to more effectively address a research question. Maximum funding is for $375,000 in direct costs (plus indirect costs). The period of performance is not to exceed 2 years.

    A pre-application is required and is due April 26, 2012. Application submission is by invitation only.

  4. Impact Award - Investigators at or above the level of Assistant Professor (or equivalent) are eligible. This award supports unique research projects that focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately have a major impact on the understanding, prevention, and/or treatment of breast cancer. Maximum funding is for $2 million in direct costs (plus indirect costs). The period of performance is not to exceed 5 years.

    A pre-application is required and is due May 3, 2012. Application submission is by invitation only.

  5. Innovator Award - Investigators who are an Associate Professor or above (or equivalent) are eligible. This award supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field. It provides the opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the end of breast cancer. Maximum funding is for $5 million in direct costs (plus indirect costs). The period of performance is not to exceed 5 years.

    A nomination is required and self-nominations are accepted; the letter of intent is due May 3, 2012. Application submission is by invitation only.

  6. Postdoctoral Fellowship Award - Eligible investigators must have completed a doctoral or medical degree. Investigators must have no more than 2 years experience in the proposed research setting and no more than 4 years of postdoctoral research experience as of the application deadline. The mentor or formal co-mentor must have breast cancer research experience, including current funding and publications. This award supports the training of exceptionally talented recent doctoral graduates. Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research. Proposed research should address a critical problem in breast cancer research. Maximum funding is for $300,000 in direct costs ($100K per year; plus indirect costs). The period of performance is not to exceed 3 years.

    Letters of intent are due April 5, 2012. Applications are due April 19, 2012.

  7. Transformative Vision Award - Independent investigators at any academic level (or equivalent) are eligible. This award supports a research effort to realize a vision for dramatically affecting the prevention or treatment of breast cancer as quickly as possible. Teams must include consumer advocates who will be integrated into the planning and implementation of the research project. Applications with multiple PIs are allowed; however, PIs should have demonstrated experience in successfully leading large, focused projects. Maximum funding is $12 million in direct costs (plus indirect costs). The period of performance is not to exceed 5 years.

    A pre-proposal is required and is due May 3, 2012. Application submission is by invitation only.

  8. Pre-applications must be submitted through the CDMRP eReceipt WebsiteExternal Web Site Policy prior to the pre-application deadline. Applications must be submitted through Grants.govExternal Web Site Policy.

    Learn more about DOD's FY12 BCRP Funding OpportunitiesExternal Web Site Policy.

    Return to Top